DOCM — DocMorris AG Income Statement
0.000.00%
- CH₣203.39m
- CH₣340.99m
- CH₣1.12bn
Annual income statement for DocMorris AG, fiscal year end - December 31st, CHF millions except per share, conversion factor applied.
2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1,727 | 931 | 969 | 1,017 | 1,124 |
| Cost of Revenue | |||||
| Gross Profit | 266 | 160 | 203 | 217 | 250 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 1,920 | 1,068 | 1,046 | 1,106 | 1,224 |
| Operating Profit | -194 | -137 | -76.8 | -89.3 | -99.8 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -227 | -169 | -119 | -103 | -122 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -226 | -171 | -118 | -97.3 | -134 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -226 | -171 | 82.3 | -97.3 | -134 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -226 | -171 | 82.3 | -97.3 | -134 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -10.9 | -7.49 | -5 | -4.56 | -3.42 |
| Dividends per Share |